ClinicalTrials.gg
CompletedNCT07892560Updated Oct 23, 2026

Effects of Different Footbath Immersion Depths on Sleep Quality Among Older Adults in Long-Term Care Facilities

An interventional study of Ankle-Level Warm-Water Footbath and Below-Knee Warm-Water Footbath in Sleep Quality, sponsored by Cai-Syuan Jiang. Completed at 6 sites in Taiwan. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Cai-Syuan Jiang · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 10 months after the study started (first participant enrolled Dec 2024, registered Oct 2026).
Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Sleep disturbances are common among older adults residing in long-term care facilities. Warm-water footbaths may help improve sleep quality; however, different immersion depths may affect the body's response to warming.

This study examined the effects of warm-water footbaths at different immersion depths on subjective and objective sleep quality among older adults living in long-term care facilities.

A total of 40 older adults aged 65 years or older from six long-term care facilities in southern Taiwan participated in a crossover study. The study compared three conditions: ankle-level footbaths, below-knee footbaths, and routine care without a footbath.

During the footbath interventions, participants immersed both feet in water at 42°C for 15 minutes approximately one hour before bedtime. Subjective sleep quality was assessed using the Verran and Snyder-Halpern Sleep Scale, and objective sleep quality was measured using wrist actigraphy.

02

Conditions studied

  • Sleep Quality

Keywords

  • footbath
  • Sleep quality
  • Older adults
  • Long-term care facilities
  • passive heating
03

In context

Sleep Initiation and Maintenance Disorders

1,930 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 612 are open to participants now.

This study's enrollment of 40 is below the median of 72 across 1,689 interventional studies indexed under Sleep Initiation and Maintenance Disorders.

Browse Sleep Initiation and Maintenance Disorders studies →

Lead sponsor

This is the only study on the registry with Cai-Syuan Jiang as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Aged 65 years or older.
  2. Resided in a long-term care facility for at least 3 months.
  3. Intact cognitive function, defined as a Short Portable Mental Status Questionnaire (SPMSQ) score ≥ 7 after adjustment for educational level.
  4. Experienced sleep disturbances, defined as a Pittsburgh Sleep Quality Index (PSQI) score > 5.

Exclusion criteria

Exclusion Criteria:

  1. Acute illness.
  2. Psychiatric illness.
  3. Lower extremity neuropathy.
  4. Foot wounds.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Sequence 1: Ankle-Level First

    Twenty participants received ankle-level warm-water footbaths, followed by routine care without footbaths, and then below-knee warm-water footbaths. Each condition lasted two days.

    Other: Ankle-Level Warm-Water Footbath · Other: Below-Knee Warm-Water Footbath

  • Experimental
    Sequence 2: Below-Knee First

    Twenty participants received below-knee warm-water footbaths, followed by routine care without footbaths, and then ankle-level warm-water footbaths. Each condition lasted two days.

    Other: Ankle-Level Warm-Water Footbath · Other: Below-Knee Warm-Water Footbath

Interventions

  • OtherAnkle-Level Warm-Water Footbath

    Participants immersed both feet in warm water at 42°C up to the ankle level for 15 minutes, approximately one hour before bedtime, on two consecutive days.

  • OtherBelow-Knee Warm-Water Footbath

    Participants immersed both feet and lower legs in warm water at 42°C up to below the knees for 15 minutes, approximately one hour before bedtime, on two consecutive days.

06

What researchers measure

Primary outcomes

  1. Subjective Sleep Quality Measured by the Verran and Snyder-Halpern Sleep Scale

    Subjective sleep quality was assessed using the 15-item Verran and Snyder-Halpern Sleep Scale (VSH). Each item is scored from 0 to 100, with a total score ranging from 0 to 1,500. Higher total scores indicate better subjective sleep quality. The VSH was completed before 9:00 a.m. each morning to assess sleep quality during the previous night. For each study condition, the scores from two consecutive mornings were averaged and compared across the three conditions.

    Time frame: Over seven consecutive days, from baseline to completion of the interventions, sleep quality was assessed before 9:00 a.m. each morning: once after the baseline night and twice after each two-night condition (ankle-level footbath, routine care, below-kne

  2. Total Sleep Time (TST) Measured by Wrist Actigraphy

    Total sleep time (TST) was measured using wrist actigraphy and expressed in minutes. It represents the total time spent asleep during the nighttime sleep period. The device was worn on the nondominant wrist overnight. During footbath conditions, it was fitted after footbath completion; during routine care, it was fitted one hour before bedtime. Devices were collected the following morning before 9:00 a.m. TST values from two consecutive nights under each condition were averaged for analysis.

    Time frame: Over seven consecutive nights per participant, from baseline to completion of the interventions, total sleep time was assessed nightly: once at baseline and twice for each two-night condition (ankle-level footbath, routine care, below-knee footbath).

  3. Sleep Latency (SL) Measured by Wrist Actigraphy

    Sleep latency (SL) was measured using wrist actigraphy and expressed in minutes. It represents the time from bedtime to sleep onset. The device was worn overnight on the nondominant wrist. During footbath conditions, it was fitted after footbath completion; during routine care, it was fitted one hour before bedtime. Devices were collected the following morning before 9:00 a.m. SL values from two consecutive nights under each condition were averaged for analysis.

    Time frame: Over seven consecutive nights per participant, from baseline to completion of the interventions, sleep latency was assessed nightly: once at baseline and twice for each two-night condition (ankle-level footbath, routine care, below-knee footbath).

  4. Wake After Sleep Onset (WASO) Measured by Wrist Actigraphy

    Wake after sleep onset (WASO) was measured using wrist actigraphy and expressed in minutes. It represents the total time spent awake after initially falling asleep during the nighttime sleep period. The device was worn overnight on the nondominant wrist. During footbath conditions, it was fitted after footbath completion; during routine care, it was fitted one hour before bedtime. Devices were collected the following morning before 9:00 a.m. WASO values from two consecutive nights under each condition were averaged for analysis.

    Time frame: Over seven consecutive nights per participant, from baseline to completion of the interventions, wake after sleep onset was assessed nightly: once at baseline and twice for each two-night condition (ankle-level footbath, routine care, below-knee footbath

  5. Sleep Efficiency (SE) Measured by Wrist Actigraphy

    Sleep efficiency (SE) was measured using wrist actigraphy and expressed as a percentage. It was calculated as total sleep time divided by time in bed, multiplied by 100. Higher percentages indicate greater sleep efficiency. The device was worn overnight on the nondominant wrist. During footbath conditions, it was fitted after footbath completion; during routine care, it was fitted one hour before bedtime. Devices were collected the following morning before 9:00 a.m. SE values from two consecutive nights under each condition were averaged for analysis.

    Time frame: Over seven consecutive nights per participant, from baseline to completion of the interventions, sleep efficiency was assessed nightly: once at baseline and twice for each two-night condition (ankle-level footbath, routine care, below-knee footbath).

07

Study locations

6 sites
  • Chiayi City Private Boren Elderly Care Center
    Chiayi City, Chiayi City 600, Taiwan
  • Lantan Jiafu Nursing Home
    Chiayi City, Chiayi City 600, Taiwan
  • Ruitai Nursing Home (Guangcai Branch)
    Chiayi City, Chiayi City 600, Taiwan
  • Zhongxiao Nursing Home
    Chiayi City, Chiayi City 600, Taiwan
  • Fumao Garden Nursing Home
    Shuishang, Chiayi County 608, Taiwan
  • Madou Sin-Lau Nursing Home, the Presbyterian Church in Taiwan
    Madou, Tainan City 721, Taiwan
08

References and documents

Individual participant data

Plan to share: No — There are no plans to share individual participant data (IPD) from this study.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07892560
Lead sponsor
Cai-Syuan Jiang
Responsible party
Cai-Syuan Jiang (Lecturer, Chung-Jen Junior College of Nursing, Health Sciences and Management) — Sponsor-investigator
First posted
Oct 23, 2026
Start date
Dec 1, 2024
Primary completion
Jan 27, 2025
Completion
Jan 27, 2025
Last update
Oct 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion